The Center for Communicable Disease Dynamics (CCDD) at Harvard School of Public Health (HSPH) will serve as a national and international center for research, teaching, and outreach to public health decision makers and other stakeholders in infectious disease modeling and epidemiology. The Center will expand and augment thriving training programs in infectious disease epidemiology and health decision science while strengthening connections within Harvard University and the surrounding area to draw in bioinformaticians, biostatisticians, evolutionary biologists, and others to activities related to infectious disease modeling and data analysis. Substantive research will focus on antimicrobial resistance, communicable disease seasonality, and the broad area of policy decisions around the allocation of scarce control measures. We will also develop novel methodology, emphasizing tools for analyzing emerging epidemics and directing control measures to optimize their effectiveness, as well as on the use of genetic and ultimately genome sequence data to track epidemics and to detect the effects of natural selection on pathogen populations. The Center will have numerous activities to make its resources, people, and methods widely available and to maintain productive interactions with public health professionals, decision makers and others. Software, including an epidemic analysis """"""""dashboard,"""""""" will be developed in partnership with public health collaborators from the US and Hong Kong. A short course in infectious disease modeling will be designed and offered annually at rotating sites on several continents;materials for this course and for a novel course on infectious disease statistics (to be developed at HSPH) will be made available by web. An annual symposium on a topic of public health importance will host academic and policymaking experts. Educational activities for science journalists will be set up. Short-term visiting fellowships for CDC and other scientists will be set up to facilitate collaborations, and a semester sabbatical for a faculty member from a minority serving institution (MSI) will be set up. Additional activities for outreach to disadvantaged group members will occur, including an """"""""ambassador"""""""" program and funded masters studentships with matching university funds. Intensive efforts will be made to integrate research, outreach, and teaching functions.

Public Health Relevance

Infectious disease modeling is an increasingly important part of decision making about the use and funding of interventions to control the spread of diseases. This Center will meet needs for enhanced training of modelers, better communication between modelers and policymakers, better methods and software for infectious disease data analysis, and enhanced understanding of key questions in infectious disease dynamics.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM088558-03
Application #
8132887
Study Section
Special Emphasis Panel (ZGM1-CBCB-5 (MI))
Program Officer
Hagan, Ann A
Project Start
2009-09-15
Project End
2014-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
3
Fiscal Year
2011
Total Cost
$2,914,212
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Hitchings, Matt D T; Lipsitch, Marc; Wang, Rui et al. (2018) Competing Effects Of Indirect Protection And Clustering On The Power Of Cluster-Randomized Controlled Vaccine Trials. Am J Epidemiol :
Kahn, Rebecca; Hitchings, Matt; Bellan, Steven et al. (2018) Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials. Clin Trials 15:207-211
Liu, Yang; Lam, Kwok-Fai; Wu, Joseph T et al. (2018) Geographically weighted temporally correlated logistic regression model. Sci Rep 8:1417
Zhang, Hongjun; Xiong, Qian; Wu, Peng et al. (2018) Influenza-associated mortality in Yancheng, China, 2011-15. Influenza Other Respir Viruses 12:98-103
Lewnard, Joseph A; Tedijanto, Christine; Cowling, Benjamin J et al. (2018) Measurement of Vaccine Direct Effects Under the Test-Negative Design. Am J Epidemiol 187:2686-2697
Babu, Tara M; Perera, Ranawaka A P M; Wu, Joseph T et al. (2018) Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis 218:1054-1060
Ali, Sheikh Taslim; Cowling, Benjamin J; Lau, Eric H Y et al. (2018) Mitigation of Influenza B Epidemic with School Closures, Hong Kong, 2018. Emerg Infect Dis 24:2071-2073
Peak, Corey M; Reilly, Amanda L; Azman, Andrew S et al. (2018) Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects. PLoS Negl Trop Dis 12:e0006257
Lewnard, Joseph A; Cobey, Sarah (2018) Immune History and Influenza Vaccine Effectiveness. Vaccines (Basel) 6:
Wesolowski, Amy; Taylor, Aimee R; Chang, Hsiao-Han et al. (2018) Mapping malaria by combining parasite genomic and epidemiologic data. BMC Med 16:190

Showing the most recent 10 out of 462 publications